US loss of exclusivity · Oncology
Venclexta
AbbVie
2032
US generics from
2025
Today: 2026
2037
2025 worldwide sales
$2.8B
Date basis
Patent-expiry estimate
US generics
Filed with the FDA
Pharma Patent Cliff
by readouts.io
Data checked 8 October 2026 ·
Full Venclexta timeline →